SEOUL, Aug. 10 (Yonhap) -- SK Biopharmaceuticals Co. on Thursday reported its second-quarter net loss of 23.3 billion won (US$17.7 million), remaining in the red compared with a year ago.
The company said in a regulatory filing that it continued to post an operating loss of 18.9 billion won for the April-June period, compared with a loss of 40.1 billion won a year earlier. Revenue rose 44.1 percent to 77 billion won.
The operating loss was 249.6 percent higher than the average estimate, according to a survey by Yonhap Infomax, the financial data firm of Yonhap News Agency.
(LEAD) S. Korea stages military parade in downtown Seoul for 1st time in decade
(LEAD) Court rejects arrest warrant for opposition leader Lee over corruption charges
(2nd LD) (Asiad) S. Korean tennis player Kwon Soon-woo embroiled in controversy after 2nd-round upset
S. Korea shows off 'high-power' missiles for Armed Forces Day ceremony
(Asiad) S. Korean tennis player Kwon Soon-woo embroiled in controversy after 2nd-round upset